# CytomX Therapeutics, Inc. (CTMX)

> 医疗保健 · US · 以 USD 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/CTMX/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 11.68M | $ -38.91M | $ -43.62M | $ 5.70M | $ 302.07M |
| 2025 | $ 78.02M | $ -17.78M | $ -77.62M | $ 4.24M | $ 99.01M |
| 2024 | $ 145.16M | $ 33.50M | $ -90.96M | $ 9.39M | $ -456.0K |
| 2023 | $ 109.44M | $ -615.2K | $ -61.50M | $ 13.97M | $ -47.45M |
| 2022 | $ 59.39M | $ -110.95M | $ -125.71M | $ 18.06M | $ -85.75M |
| 2021 | $ 82.70M | $ -99.38M | $ -143.40M | $ 21.67M | $ -459.0K |
| 2020 | $ 127.85M | $ -41.89M | $ 3.76M | $ 24.87M | $ -7.77M |
| 2019 | $ 74.20M | $ -131.97M | $ -185.84M | $ 27.68M | $ 51.11M |
| 2018 | $ 78.58M | $ -111.74M | $ -104.74M | $ 0 | $ 130.88M |
| 2017 | $ 96.48M | $ -58.06M | $ 227.42M | $ 0 | $ 69.90M |
| 2016 | $ 20.70M | $ -81.04M | $ -5.79M | $ 0 | $ 78.48M |
| 2015 | $ 10.83M | $ -49.67M | $ -40.73M | $ 0 | $ 126.07M |
| 2014 | $ 7.17M | $ -45.94M | $ 42.59M | $ 2.99M | $ -78.54M |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.02 |
| 总负债 / 股东权益 | 0.26 |
| 流动比率 | 9.36 |

## 其他视图

- [指标](https://sponda.capital/zh/CTMX.md)
- [图表](https://sponda.capital/zh/CTMX/charts.md)
- [对比](https://sponda.capital/zh/CTMX/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-27。